Pure and Applied Chemistry

Pure Appl. Chem., 2008, Vol. 80, No. 8, pp. 1811-1820

http://dx.doi.org/10.1351/pac200880081811

Personalizing protein-drug interactions

References

• 1. J. Woodcock. Making Medical Products Better, Faster and Cheaper (<http://www.fda.gov/consumer/updates/criticalpath091007.html>) (2007).
• 2. C. T. Caskey. Annu. Rev. Med. 58, 1 (2007). (http://dx.doi.org/10.1146/annurev.med.58.042705.124037)
• 3. L. J. Lesko, J. Woodcock. Nat. Rev. Drug Discov. 3, 763 (2004). (http://dx.doi.org/10.1038/nrd1499)
• 4. J. R. Senior. Clin. Liver Dis. 11, 507 (2007). (http://dx.doi.org/10.1016/j.cld.2007.06.002)
• 5. W. Sadee, Z. Dai. Hum. Mol. Genet. 14, R207 (2005). (http://dx.doi.org/10.1093/hmg/ddi261)
• 6. J. A. DiMasi, R. W. Hansen, H. G. Grabowski. J. Health Econ. 22, 151 (2003). (http://dx.doi.org/10.1016/S0167-6296(02)00126-1)
• 7. J. F. Blake. Med. Chem. 1, 649 (2005). (http://dx.doi.org/10.2174/157340605774598081)
• 8. Pharmaceutical Industry Profile 2005: <http://www.phrma.org>.
• 9. C. Hodges. Paper for the 2nd Annual Cambridge Conference on Regulation, Inspection, and Improvement, Cambridge (2007).
• 10. R. W. Peck. Drug Discov. Today 12, 289 (2007). (http://dx.doi.org/10.1016/j.drudis.2007.02.004)
• 11. FDA Critical Path Initiative Fact Sheet: <http://www.fda.gov/oc/initiatives/criticalpath/factsheet.html> (2007).
• 12. G. R. Wilkinson. N. Engl. J. Med. 352, 2211 (2005). (http://dx.doi.org/10.1056/NEJMra032424)
• 13. C. Guzey, O. Spigset. Curr. Top. Med. Chem. 4, 1409 (2004). (http://dx.doi.org/10.2174/1568026043387791)
• 14. W. H. Koch. Nat. Rev. Drug Discov. 3, 749 (2004). (http://dx.doi.org/10.1038/nrd1496)
• 15. H. L. McLeod. Clin. Infect. Dis. 41, S449 (2005). (http://dx.doi.org/10.1086/431995)
• 16. dbSNP Database: <http://www.ncbi.nlm.nih.gov/projects/SNP/index.html>.
• 17. Biomarkers Definitions Working Group. Clin. Pharmacol. Ther. 69, 89 (2001). (http://dx.doi.org/10.1067/mcp.2001.113989)
• 18. European Union's Innovative Medicines Initiative: <http://www.imi-europe.org>.
• 19. J. M. Boutell, D. J. Hart, B. L. J Godber, R. Z. Kozlowski, J. M. Blackburn. Proteomics 4, 1950 (2004). (http://dx.doi.org/10.1002/pmic.200300722)
• 20. J. M. Blackburn, D. J. Hart. "Fabrication of protein function microarrays for systems-oriented proteomic analysis", in Chemical Genomics: Reviews and Protocols, E. Zanders (Ed.), Chap. 14, Humana Press, Totowa, NJ (2005). (http://dx.doi.org/10.1007/978-1-59259-948-6_14)
• 21. G. Manning, D. B. White, R. Martinez, T. Hunter, S. Sudarsanam. Science 298, 1912 (2002). (http://dx.doi.org/10.1126/science.1075762)
• 22. P. Cohen. Nat. Rev. Drug. Discov. 1, 309 (2002). (http://dx.doi.org/10.1038/nrd773)
• 23. M. A. Fabian, W. H. Biggs, D. K. Treiber, C. E. Atteridge, M. D. Azimioara, M. G. Benedetti, T. A. Carter, P. Ciceri, P. T. Edeen, M. Floyd, J. M. Ford, M. Galvin, J. L. Gerlach, R. M. Grotzfeld, S. Herrgard, D. E. Insko, M. A. Insko, A. G. Lai, J.-M. Lelias, S. A. Mehta, Z. V. Milanov, A. M. Velasco, L. M. Wodicka, H. K. Patel, P. P. Zarrinkar, D. J. Lockhart. Nat. Biotechnol. 23, 329 (2005). (http://dx.doi.org/10.1038/nbt1068)
• 24. S. Joyce, C. Wheeler, J. Blackburn, R. Fallon. Unpublished data.
• 25. M. Bantscheff, D. Eberhard, Y. Abraham, S. Bastuck, M. Boesche, S. Hobson, T. Mathieson, J. Perrin, M. Raida, C. Rau, V. Reader, G. Sweetman, A. Bauer, T. Bouwmeeester, C. Hopf, U. Kruse, G. Neubauer, N. Ramsden, J. Rick, B. Kuster, G. Drewes. Nat. Biotechnol. 25, 1035 (2007). (http://dx.doi.org/10.1038/nbt1328)
• 26. C. B. Gambacorti-Passerini, R. H. Rosalind, R. Piazza, A. Galietta, R. Rostagno, L. Scapozza. Lancet Oncol. 4, 75 (2003). (http://dx.doi.org/10.1016/S1470-2045(03)00979-3)
• 27. J. G. Paez, P. A. Janne, J. C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F. J. Kaye, N. Lindeman, T. J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M. J. Eck, W. R. Sellers, B. E. Johnson, M. Meyerson. Science 304, 1497 (2004). (http://dx.doi.org/10.1126/science.1099314)
• 28. S. H. Yang, L. E. Mechanic, P. Yang, M. T Landi, E. D. Bowman, J. Wampfler, D. Meerzaman, K. M. Hong, F. Mann, T. Dracheva, J. Fukuoka, W. Travis, N. E. Caporaso, C. C. Harris, J. Jen. Clin. Cancer Res. 11, 2106 (2005). (http://dx.doi.org/10.1158/1078-0432.CCR-04-1853)
• 29. T. J. Lynch, D. W. Bell, R. Sordella, S. Gurubhagavatula, R. A. Okimoto, B. W. Brannigan, P. L. Harris, S. M. Haserlat, J. G. Supko, F. G. Haluska, D. N. Louis, D.C. Christiani, J. Settleman, D. A. Haber. N. Engl. J. Med. 351, 1260 (2004). (http://dx.doi.org/10.1056/NEJMcpc049012)
• 30. H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I. I. Wistuba, K. M. Fong, H. Lee, S. Toyooka, N. Shimizu, T. Fujisawa, Z. Feng, J. A. Roth, J. Herz, J. D. Minna, A. F. Gazdar. J. Natl. Cancer Inst. 97, 326 (2005).
• 31. P. B. Danielson. Curr. Drug Metab. 3, 561 (2002). (http://dx.doi.org/10.2174/1389200023337054)
• 32. F. P. Guengerich. Mol. Interv. 3, 194 (2003). (http://dx.doi.org/10.1124/mi.3.4.194)
• 33. M. Ingelman-Sundberg. Trends Pharmacol. Sci. 25, 193 (2004). (http://dx.doi.org/10.1016/j.tips.2004.02.007)
• 34. PharmGKB Database: <http://www.pharmgkb.org/>.
• 35. R. Delgoda, A. C. Westlake. Toxicol. Rev. 23, 239 (2004). (http://dx.doi.org/10.2165/00139709-200423040-00004)
• 36. E. Mills, C. Cooper, D. Seely, I. Kanfer. Nutr. J. 31, 4 (2005).
• 37. M. Ingelman-Sundberg. Drug Metab. Dispos. 29, 570 (2001).
• 38. T. Dervieux, B. Meshkin, B. Neri. Mutat. Res. 573, 180 (2005). (http://dx.doi.org/10.1016/j.mrfmmm.2004.07.025)
• 39. F. J. Thomas, H. L. McLeod, J. W. Watters. Curr. Top. Med. Chem. 4, 1397 (2004). (http://dx.doi.org/10.2174/1568026043387638)
• 40. A. Fantuzzi, M. Fairhead, G. Gilardi. J. Am. Chem. Soc. 126, 5040 (2004). (http://dx.doi.org/10.1021/ja049855s)
• 41. M. Dyson, N. Bockett, D. J. Hart, B. Godber, R. Z. Kozlowski, J. M. Blackburn. PCT application no. PCT//IB03/05258, filed 16 September 2003.
• 42. M. Lee, C. B. Park, J. S. Dordick, D. S. Clark. Proc. Natl. Acad. Sci. USA 102, 983 (2005). (http://dx.doi.org/10.1073/pnas.0406755102)
• 43. FDA Guidance for Industry: <www.fda.gov/cder/guidance/6400fnl.pdf> (2005).
• 44. A. Katnelson. Nat. Biotechnol. 23, 510 (2005). (http://dx.doi.org/10.1038/nbt0505-510)
• 45. FDA's critical path initiative-science enhancing the health and well-being of all Americans: <http://www.fda.gov/oc/initiatives/criticalpath/initiative.html> (2007).